BTAIVSNVCR• 12 Months (Normalized)
BTAI vs NVCR (BioXcel Therapeutics Inc. vs NovoCure Limited)
Showing Closing Date Range from Sep, 14, 2025 to Sep, 14, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BTAI Performance $0.05
+%
BioXcel Therapeutics Inc.
Normalized Baseline0.00%
NVCR Performance $16.07
+26.3%
NovoCure Limited
Normalized Baseline0.00%
Alpha Spread Margin NVCR LEADS
-26.3%
NVCR outperforming by 26.30%
BTAINVCR
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BTAI NVCR
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(251 dates)
| Date | BTAI Price | BTAI Gain (%) | NVCR Price | NVCR Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 14, 2026 | $- | $16.07 | +26.30% | - | |
| Sep 11, 2026 | $0.05 | -98.39% | $15.51 | +21.93% | -120.32% |
| Sep 10, 2026 | $0.05 | -98.42% | $15.35 | +20.68% | -119.10% |
| Sep 09, 2026 | $0.05 | -98.52% | $15.63 | +22.88% | -121.40% |
| Sep 08, 2026 | $0.04 | -98.64% | $16.85 | +32.47% | -131.11% |
| Sep 04, 2026 | $0.07 | -97.67% | $17.94 | +41.04% | -138.71% |
| Sep 03, 2026 | $0.12 | -96.28% | $17.64 | +38.68% | -134.96% |
| Sep 02, 2026 | $0.11 | -96.62% | $17.83 | +40.17% | -136.79% |
| Sep 01, 2026 | $0.14 | -95.68% | $17.38 | +36.64% | -132.32% |
| Aug 31, 2026 | $0.16 | -94.86% | $17.65 | +38.76% | -133.62% |
| Aug 28, 2026 | $0.18 | -94.29% | $17.82 | +40.09% | -134.38% |
| Aug 27, 2026 | $0.72 | -77.32% | $17.99 | +41.43% | -118.75% |
| Aug 26, 2026 | $0.78 | -75.39% | $17.89 | +40.64% | -116.03% |
| Aug 25, 2026 | $0.74 | -76.59% | $17.62 | +38.52% | -115.11% |
| Aug 24, 2026 | $0.76 | -75.99% | $16.76 | +31.76% | -107.75% |
Page 1 of 17